Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective MRP1-mediated multidrug resistant modulator characterized by Vertex

July 24, 2003

Austrianova's cell therapy receives European orphan drug status

July 23, 2003

MediciNova studying potential of SOCC-specific inhibitors for cancer

July 23, 2003

SkyePharma licenses European Depocyte rights to Mundipharma

July 23, 2003

Antitumor activity of the novel coxib CS-706 (R-109339) in mice

July 23, 2003

U. of Oklahoma researchers identify novel proapoptotic antitumor compounds

July 23, 2003

Small-molecule inhibitor of IGF-IR kinase activity characterized at cancer meeting

July 22, 2003

CanBas identifies peptide with the ability to abrogate the G2 cell cycle checkpoint

July 22, 2003

Small-molecule Bcl-xL/Bcl-2 antagonist with potential for combination therapy

July 22, 2003

AACR news: agonist antibodies to TRAIL-R2 show promise for the treatment of cancer

July 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...